Cargando…

Independent Tailoring of Dose and Drug Release via a Modularized Product Design Concept for Mass Customization

Independent individualization of multiple product attributes, such as dose and drug release, is a crucial overarching requirement of pharmaceutical products for individualized therapy as is the unified integration of individualized product design with the processes and production that drive patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Govender, Rydvikha, Abrahmsén-Alami, Susanna, Larsson, Anette, Borde, Anders, Liljeblad, Alexander, Folestad, Staffan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465528/
https://www.ncbi.nlm.nih.gov/pubmed/32823877
http://dx.doi.org/10.3390/pharmaceutics12080771
_version_ 1783577607916224512
author Govender, Rydvikha
Abrahmsén-Alami, Susanna
Larsson, Anette
Borde, Anders
Liljeblad, Alexander
Folestad, Staffan
author_facet Govender, Rydvikha
Abrahmsén-Alami, Susanna
Larsson, Anette
Borde, Anders
Liljeblad, Alexander
Folestad, Staffan
author_sort Govender, Rydvikha
collection PubMed
description Independent individualization of multiple product attributes, such as dose and drug release, is a crucial overarching requirement of pharmaceutical products for individualized therapy as is the unified integration of individualized product design with the processes and production that drive patient access to such therapy. Individualization intrinsically demands a marked increase in the number of product variants to suit smaller, more stratified patient populations. One established design strategy to provide enhanced product variety is product modularization. Despite existing customized and/or modular product design concepts, multifunctional individualization in an integrated manner is still strikingly absent in pharma. Consequently, this study aims to demonstrate multifunctional individualization through a modular product design capable of providing an increased variety of release profiles independent of dose and dosage form size. To further exhibit that increased product variety is attainable even with a low degree of product modularity, the modular design was based upon a fixed target dosage form size of approximately 200 mm(3) comprising two modules, approximately 100 mm(3) each. Each module contained a melt-extruded and molded formulation of 40% w/w metoprolol succinate in a PEG1500 and Kollidon(®) VA64 erodible hydrophilic matrix surrounded by polylactic acid and/or polyvinyl acetate as additional release rate-controlling polymers. Drug release testing confirmed the generation of predictable, combined drug release kinetics for dosage forms, independent of dose, based on a product’s constituent modules and enhanced product variety through a minimum of six dosage form release profiles from only three module variants. Based on these initial results, the potential of the reconfigurable modular product design concept is discussed for unified integration into a pharmaceutical mass customization/mass personalization context.
format Online
Article
Text
id pubmed-7465528
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-74655282020-09-04 Independent Tailoring of Dose and Drug Release via a Modularized Product Design Concept for Mass Customization Govender, Rydvikha Abrahmsén-Alami, Susanna Larsson, Anette Borde, Anders Liljeblad, Alexander Folestad, Staffan Pharmaceutics Article Independent individualization of multiple product attributes, such as dose and drug release, is a crucial overarching requirement of pharmaceutical products for individualized therapy as is the unified integration of individualized product design with the processes and production that drive patient access to such therapy. Individualization intrinsically demands a marked increase in the number of product variants to suit smaller, more stratified patient populations. One established design strategy to provide enhanced product variety is product modularization. Despite existing customized and/or modular product design concepts, multifunctional individualization in an integrated manner is still strikingly absent in pharma. Consequently, this study aims to demonstrate multifunctional individualization through a modular product design capable of providing an increased variety of release profiles independent of dose and dosage form size. To further exhibit that increased product variety is attainable even with a low degree of product modularity, the modular design was based upon a fixed target dosage form size of approximately 200 mm(3) comprising two modules, approximately 100 mm(3) each. Each module contained a melt-extruded and molded formulation of 40% w/w metoprolol succinate in a PEG1500 and Kollidon(®) VA64 erodible hydrophilic matrix surrounded by polylactic acid and/or polyvinyl acetate as additional release rate-controlling polymers. Drug release testing confirmed the generation of predictable, combined drug release kinetics for dosage forms, independent of dose, based on a product’s constituent modules and enhanced product variety through a minimum of six dosage form release profiles from only three module variants. Based on these initial results, the potential of the reconfigurable modular product design concept is discussed for unified integration into a pharmaceutical mass customization/mass personalization context. MDPI 2020-08-14 /pmc/articles/PMC7465528/ /pubmed/32823877 http://dx.doi.org/10.3390/pharmaceutics12080771 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Govender, Rydvikha
Abrahmsén-Alami, Susanna
Larsson, Anette
Borde, Anders
Liljeblad, Alexander
Folestad, Staffan
Independent Tailoring of Dose and Drug Release via a Modularized Product Design Concept for Mass Customization
title Independent Tailoring of Dose and Drug Release via a Modularized Product Design Concept for Mass Customization
title_full Independent Tailoring of Dose and Drug Release via a Modularized Product Design Concept for Mass Customization
title_fullStr Independent Tailoring of Dose and Drug Release via a Modularized Product Design Concept for Mass Customization
title_full_unstemmed Independent Tailoring of Dose and Drug Release via a Modularized Product Design Concept for Mass Customization
title_short Independent Tailoring of Dose and Drug Release via a Modularized Product Design Concept for Mass Customization
title_sort independent tailoring of dose and drug release via a modularized product design concept for mass customization
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465528/
https://www.ncbi.nlm.nih.gov/pubmed/32823877
http://dx.doi.org/10.3390/pharmaceutics12080771
work_keys_str_mv AT govenderrydvikha independenttailoringofdoseanddrugreleaseviaamodularizedproductdesignconceptformasscustomization
AT abrahmsenalamisusanna independenttailoringofdoseanddrugreleaseviaamodularizedproductdesignconceptformasscustomization
AT larssonanette independenttailoringofdoseanddrugreleaseviaamodularizedproductdesignconceptformasscustomization
AT bordeanders independenttailoringofdoseanddrugreleaseviaamodularizedproductdesignconceptformasscustomization
AT liljebladalexander independenttailoringofdoseanddrugreleaseviaamodularizedproductdesignconceptformasscustomization
AT folestadstaffan independenttailoringofdoseanddrugreleaseviaamodularizedproductdesignconceptformasscustomization